Drug · DIN 02548895
RIVA-AZITHROMYCIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 18, 2024.
- Drug Identification Number (DIN)
- 02548895
- Company (DIN owner)
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Azithromycin J01FA10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) | 600 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 18, 2024: NOC 33468Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named RIVA-AZITHROMYCIN
- DIN 02275309 · Marketed